1. Home
  2. AlgoTherapeutics

Category: Omnes

Omnes, Bpifrance back €12m Series A round for cancer treatment side-effect drug developer AlgoTherapeutix

French biotech company AlgoTherapeutix has raised €12m in a Series A round led by Bpifrance through its InnoBio 2 fund alongside co-investor Omnes.

Omnes seals debut Irish renewables deal as firm continues Capenergie 4 raise beyond €500m goal

Paris-based private equity and infrastructure investor Omnes has made its first Irish renewables deal by backing solar PV developer Power Capital Renewable Energy.

Omnes reinvests in recycled wood pellet maker Biosyl a year after initial investment

Omnes has completed its eighth sponsorless deal through its reinvestment in wood pellet manufacturer Biosyl, a year after it first invested in the business.

Deeptech cybersecurity business Sekoia gets Omnes, Alliance Entreprendre backing

French deeptech cybersecurity business Sekoia has picked up €10m of funding from private equity investor Omnes and Alliance Entreprendre.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.